5th April 2019
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces: TR-1: Standard form for notification of major holdings Download News5th April 2019
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces: TR-1: Standard form for notification of major holdings Download News